Walleye Trading’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.3K | Hold |
14,000
| – | – | ﹤0.01% | 808 |
|
|
2025
Q1 | $48.9K | Hold |
14,000
| – | – | ﹤0.01% | 763 |
|
|
2024
Q4 | $45.8K | Hold |
14,000
| – | – | ﹤0.01% | 835 |
|
|
2024
Q3 | $53.9K | Hold |
14,000
| – | – | ﹤0.01% | 808 |
|
|
2024
Q2 | $43.3K | Hold |
14,000
| – | – | ﹤0.01% | 1043 |
|
|
2024
Q1 | $36.1K | Buy |
+14,000
| New | +$36.1K | ﹤0.01% | 1167 |
|
|
2022
Q1 | – | Sell |
-48,743
| Closed | -$190K | – | 1890 |
|
|
2021
Q4 | $190K | Sell |
48,743
-28,053
| -37% | -$109K | ﹤0.01% | 1259 |
|
|
2021
Q3 | $329K | Buy |
+76,796
| New | +$329K | ﹤0.01% | 860 |
|
|
2019
Q4 | – | Sell |
-22,658
| Closed | -$35K | – | 1237 |
|
|
2019
Q3 | $35K | Buy |
+22,658
| New | +$35K | ﹤0.01% | 1000 |
|
|
2018
Q4 | – | Sell |
-21,578
| Closed | -$204K | – | 1372 |
|
|
2018
Q3 | $204K | Buy |
+21,578
| New | +$204K | ﹤0.01% | 1090 |
|
|
2017
Q1 | – | Sell |
-7,000
| Closed | -$17K | – | 1626 |
|
|
2016
Q4 | $17K | Buy |
+7,000
| New | +$17K | ﹤0.01% | 1378 |
|